| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $238.1M | -33.1% |
| SG&A Expense | $66.8M | +1.0% |
| Operating Income | -$316.3M | +25.1% |
| Income Tax | $0 | — |
| Net Income | -$248.2M | +35.0% |
| EPS (Basic) | -$2.50 | +54.0% |
| EPS (Diluted) | -$2.50 | +54.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.9M | -66.1% |
| Current Assets | $481.0M | -34.7% |
| Total Assets | $491.1M | -33.9% |
| Current Liabilities | $26.6M | -68.8% |
| Total Liabilities | $32.8M | -62.0% |
| Stockholders' Equity | $458.3M | -30.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$303.9M | -79.1% |
| Capital Expenditures | $1.2M | -45.6% |
| Investing Cash Flow | $154.9M | +134.6% |
| Financing Cash Flow | $5.4M | -99.1% |
| Free Cash Flow | -$305.2M | -77.4% |